GSA CAPITAL PARTNERS LLP

Position in BMEA — Biomea Fusion, Inc.

CIK 1362033 LONDON, X0

Position in BMEA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$317,549

+$272,388 QoQ

Shares Held

216,020

+631.8% QoQ

Ownership

0.298%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#20

of 61 holders

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. BMEA ranks #105 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$317,549	216,020	+631.8%	Shares	Sole	2026-08-06
2026-03-31	$45,161	29,517	+30.1%	Shares	Sole	2026-05-08
2025-12-31	$28,140	22,694	-84.4%	Shares	Sole	2026-02-06
2025-03-31	$310,769	145,901	+52.6%	Shares	Sole	2025-05-08
2024-12-31	$371,063	95,635	-2.7%	Shares	Sole	2025-02-07
2024-09-30	$992,739	98,291	-36.8%	Shares	Sole	2024-11-05
2024-06-30	$700,069	155,571	+338.9%	Shares	Sole	2024-08-15
2024-03-31	$529,887	35,444	-33.4%	Shares	Sole	2024-05-03
2023-12-31	$772,376	53,194	+29.6%	Shares	Sole	2024-02-16
2023-09-30	$564,820	41,048	+16.8%	Shares	Sole	2023-11-15
2023-06-30	$771,235	35,136	-3.7%	Shares	Sole	2023-08-14
2023-03-31	$1,131,089	36,475	+35.9%	Shares	Sole	2023-05-12
2022-12-31	$226,303	26,845	+103.5%	Shares	Sole	2023-02-13
2022-09-30	$129,027	13,193	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.